摘要
细胞周期检查点激酶1(Chk1)是由抑癌基因Chk1编码的丝氨酸/苏氨酸(Ser/Thr激酶),广泛存在于哺乳动物细胞内。近年来,多项国内外研究表明Chk1及其抑制剂能调控肿瘤的形成与发展。基于此,本文以Chk1及其抑制剂的概况和应用为基础,总结其多向调控肿瘤细胞的作用机制,旨在为Chk1及其抑制剂的临床应用和开发、相关药物的研发提供参考。
Cell cycle checkpoint kinase 1(Chk1)is a serine/threonine(Ser/Thr kinase)encoded by the tumor suppressor gene Chk1 and is widely found in mammalian cells.In recent years,a number of domestic and foreign studies have shown that Chk1 and its inhibitors can regulate the formation and development of tumors.Based on this,based on the profile and application of Chk1 and its inhibitors,this paper summarizes the mechanism of multi-directional regulation of tumor cells,aiming to provide reference for the clinical application and development of Chk1 and its inhibitors,and the development of related drugs.
作者
于祥菊
宋碧莹
刘滢
吕冬霞
YU Xiang-ju;SONG Bi-ying;LIU Ying;LYU Dong-xia(Jiamusi University,Jiamusi 154007,Heilongjiang,China)
出处
《医学信息》
2019年第19期39-42,46,共5页
Journal of Medical Information
基金
佳木斯大学校长创新创业基金项目(编号:XZYF2018-45)
